Skip to main content

Table 3 Predictors of progression-free survival

From: I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma

  Univariate analysis Multivariate analysis
Hazard ratio 95% CI P value Hazard ratio 95% CI P value
Tumor thrombi
 No 1    1   
 Yes 3.837 1.658–8.878 0.002 4.480 0.922–21.759 0.063
BCLC stage
 A 1    1   
 B 2.186 1.218–3.921 0.009 2.728 1.443–5.158 0.002
 C 5.978 2.207–16.196  < 0.001 2.437 0.426 –13.958 0.317
Treatment protocols
 Combined 1    1   
 TACE alone 1.884 1.095–3.240 0.022 2.392 1.297–4.413 0.003
  1. AFP Alphafetoprotein, BCLC Barcelona clinic liver cancer, TACE transcatheter arterial chemoembolization